EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting palmitoylation: A novel frontier in cancer biology and immunotherapy

Ye Yang, Enqi Zhang, Xuanli Mao, Guohong Liu, Yunbao Pan

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-02 · 1881 (1) · 189509

DOI: 10.1016/j.bbcan.2025.189509 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-02. Verfasst von Ye Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China; Second Clinical Hospital of Wuhan Un…. Hauptthemen laut MEDLINE: Lipoylation, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: Yellow Crane Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein palmitoylation, a dynamic post-translational modification involving the reversible attachment of palmitic acid to cysteine residues, has emerged as a pivotal regulator of tumor biology. This review synthesizes the latest insights into palmitoylation's contributions to cancer, emphasizing its roles in metabolic reprogramming, oncogenic signaling, immune modulation, and therapeutic responsiveness. The ZDHHC family of palmitoyltransferases, in concert with depalmitoylases, coordinates intricate regulatory networks that govern protein localization, stability, and interactions essential for tumor proliferation, invasion, and immune evasion. Driven by dysregulated lipid metabolism, aberrant palmitoylation modulates key pathways such as AKT-mTOR and Wnt/β-catenin, while also stabilizing immune checkpoints like PD-L1 and TIM-3 to sculpt an immunosuppressive tumor microenvironment. Advances in multi-omics integration and detection technologies, including high-resolution mass spectrometry and imaging modalities, have deepened our mechanistic understanding of these processes. Preclinical evidence underscores the promise of small-molecule inhibitors like 2-bromopalmitate and TVB-3166, which disrupt palmitoylation to inhibit tumor growth and potentiate immunotherapy. Nonetheless, hurdles in selectivity, toxicity, and resistance demand further optimization for clinical translation. Future research should focus on unraveling palmitoylation's interplay with immune dynamics and advancing biomarker-guided, personalized therapies to elevate cancer outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipoylationNeoplasmsImmunotherapyHumansTumor MicroenvironmentAnimalsProtein Processing, Post-TranslationalAcyltransferasesSignal TransductionMolecular Targeted Therapy

Stichwörter der Autor:innen

Immune checkpointsPalmitoylationTargeted therapyTumor metabolismTumor microenvironmentZDHHC

Substanzen

Acyltransferases

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China; Second Clinical Hospital of Wuhan University, Wuhan 430071, China. Electronic address: yangyemabel@outlook…
  • Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China; Second Clinical Hospital of Wuhan University, Wuhan 430071, China. Electronic address: zn7tgjtz@outlook.co…
  • Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China; Second Clinical Hospital of Wuhan University, Wuhan 430071, China. Electronic address: m3246919040@outlook…
  • Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China. Electronic address: liuguoh@outlook.com.
  • Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China; Hubei Molecular Diagnostic Clinical Medical Research Center, Wuhan 430071, China. Electronic address: pany…

Förderung

  • Yellow Crane Talents Program

Zitieren

APA

Yang, Y., Zhang, E., Mao, X., Liu, G., & Pan, Y. (2026). Targeting palmitoylation: A novel frontier in cancer biology and immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(1), 189509. https://doi.org/10.1016/j.bbcan.2025.189509

Vancouver

Yang Y, Zhang E, Mao X, Liu G, Pan Y. Targeting palmitoylation: A novel frontier in cancer biology and immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(1):189509. doi:10.1016/j.bbcan.2025.189509

BibTeX
@article{Yang2026,
  author = {Yang, Ye and Zhang, Enqi and Mao, Xuanli and Liu, Guohong and Pan, Yunbao},
  title = {Targeting palmitoylation: A novel frontier in cancer biology and immunotherapy},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  volume = {1881},
  number = {1},
  pages = {189509},
  doi = {10.1016/j.bbcan.2025.189509}
}
Kostenlos starten →